QI
CALA

QS Investors’s Calithera Biosciences, Inc CALA Stock Holding History

QS Investors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$279K Buy
+6,660
New +$293K ﹤0.01% 964

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

QS Investors's CALA Position: Q2 2021 in Review

QS Investors opened a new position in Calithera Biosciences, Inc (CALA) in Q2 2021: 6,660 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #964 among its holdings.

76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • QS Investors held 6,660 shares of Calithera Biosciences, Inc worth $279K as of Q2 2021.
  • Calithera Biosciences, Inc was a new QS Investors position in Q2 2021.
  • Calithera Biosciences, Inc made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #964 holding.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.